Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) EBIT Margin (2024 - 2025)

Historic EBIT Margin for Pyxis Oncology (PYXS) over the last 2 years, with Q2 2025 value amounting to 700.35%.

  • Pyxis Oncology's EBIT Margin changed N/A to 700.35% in Q2 2025 from the same period last year, while for Sep 2025 it was 3765.74%, marking a year-over-year change of. This contributed to the annual value of 554.07% for FY2024, which is N/A changed from last year.
  • As of Q2 2025, Pyxis Oncology's EBIT Margin stood at 700.35%.
  • Pyxis Oncology's EBIT Margin's 5-year high stood at 34.71% during Q1 2024, with a 5-year trough of 700.35% in Q2 2025.